Salt / ingredient
Olmesartan Medoxomil 20mg
Lowers blood pressure
MRP data last verified: August 2026. Source: NPPA Pharma Sahi Daam, reproduced under the NPPA copyright policy.
Private-brand substitutes: kam se zyada
More about this medicine
Reference information
About Olmesartan Medoxomil
This information is from US FDA labels, for reference only. Always follow your doctor's advice.
Common side effects
- nausea
- hyperuricemia
- dizziness
- upper respiratory infection ( 6
Safety advice
- Consult your doctor before use if pregnant or breastfeeding.
- May affect the kidneys. Tell your doctor if you have kidney problems.
- Stop use and seek emergency help if you have signs of a severe allergic reaction.
Uses
- lmesartan medoxomil and hydrochlorothiazide is indicated for the treatment of hypertension, to lower blood pressure.
- Olmesartan medoxomil and hydrochlorothiazide is not indicated for the initial therapy of hypertension .
- Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
- These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs.
- There are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide.
How to take
- he recommended starting dose of olmesartan medoxomil and hydrochlorothiazide is 40/12.5 mg once daily in patients whose blood pressure is not adequately controlled with olmesartan monotherapy.
- Dose can be titrated up to 40 /25 mg if necessary.
- The recommended starting dose of olmesartan medoxomil and hydrochlorothiazide is 20/12.5 mg once daily in patients whose blood pressure is not adequately controlled with monotherapy or who experience dose-limiting adverse reactions with hydrochlorothiazide.
- Patients titrated to the individual components (olmesartan and hydrochlorothiazide) may instead receive the corresponding dose of olmesartan medoxomil and hydrochlorothiazide.
- Recommended starting dose in patients not adequately controlled with olmesartan monotherapy, 40/12.5 mg ( 2 ) Recommended starting dose in patients not adequately controlled with hydrochlorothiazide monotherapy, 20/12.5 mg ( 2 ) Adjust dose after 2 to 4 weeks, as needed, to a maximum of 40 mg / 25 mg olmesartan / hydrochlorothiazide ( 2 )
Frequently Asked Questions about Olmesartan Medoxomil 20mg
What is the price of Olmesartan Medoxomil 20mg in India?
The price of Olmesartan Medoxomil 20mg in India depends on the manufacturer and channel. Official Government Jan Aushadhi generic rates start at ₹1.59 per unit.Private commercial brands vary from low-cost options to higher-priced branded formulations.
Is a Government Jan Aushadhi generic available for Olmesartan Medoxomil 20mg?
Olmesartan Medoxomil 20mg is listed under PMBI Jan Aushadhi (PMBI Code 992) at ₹15.94 per pack.
How to find lower-cost substitutes for Olmesartan Medoxomil 20mg?
Search the active salt formulation (Olmesartan Medoxomil 20mg) on Sasta Parcha to view private-brand substitutes ranked strictly low-to-high by per-unit price. Always consult your prescribing doctor or pharmacist before changing medicine brands.